Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

Mir Ali to Buprenorphine

This is a "connection" page, showing publications Mir Ali has written about Buprenorphine.

 
Connection Strength
 
 
 
1.516
 
  1. Ali MM, Creedon TB, Jacobus-Kantor L, Sherry TB. National trends in buprenorphine prescribing before and during the COVID-19 pandemic. J Subst Abuse Treat. 2023 01; 144:108923.
    View in: PubMed
    Score: 0.650
  2. Meinhofer A, Hinde JM, Ali MM. Substance use disorder treatment services for pregnant and postpartum women in residential and outpatient settings. J Subst Abuse Treat. 2020 03; 110:9-17.
    View in: PubMed
    Score: 0.532
  3. Jones CM, Olsen Y, Ali MM, Sherry TB, Mcaninch J, Creedon T, Juliana P, Jacobus-Kantor L, Baillieu R, Diallo MM, Thomas A, Gandotra N, Sokolowska M, Ling S, Compton W. Characteristics and Prescribing Patterns of Clinicians Waivered to Prescribe Buprenorphine for Opioid Use Disorder Before and After Release of New Practice Guidelines. JAMA Health Forum. 2023 07 07; 4(7):e231982.
    View in: PubMed
    Score: 0.170
  4. Sanmartin MX, Ali MM, Dwyer DS. Trends in buprenorphine-waivered providers in Medicaid expansion and non-expansion states by their public listing status. Subst Abus. 2022 12; 43(1):1072-1074.
    View in: PubMed
    Score: 0.164
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.